Better Dividend Stock to Buy and Hold: Pfizer or Bristol Myers Squibb?

Pfizer offers a higher dividend yield of 5.8% compared to Bristol Myers Squibb's 4.3%, making it more attractive for income investors. However, Bristol Myers Squibb maintains a safer dividend with a 55% payout ratio versus Pfizer's over 100% payout ratio. Both pharma companies face patent cliffs but have growth prospects. The article suggests Pfizer is better for maximizing income, while Bristol Myers Squibb may deliver higher total returns due to lower execution risk.